Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem
- 1 April 1996
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 27 (3) , 451-454
- https://doi.org/10.1016/0306-3623(95)02065-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissuesGeneral Pharmacology: The Vascular System, 1995
- Comparison of the effects of calcium antagonists on action potentials in rabbit sino-atrial nodeThe Japanese Journal of Pharmacology, 1995
- Effects of a Newly Synthesized Dihydropyridine, NZ-105, on Intracellular Ca Transients and Tension in Ferret Ventricular MusclesJournal of Cardiovascular Pharmacology, 1994
- Efonidipine Hydrochloride: A New Calcium AntagonistCardiovascular Drug Reviews, 1994
- The effect of a newly synthesized dihydropyrldine on Intracellular Ca++ movement in vascular smooth muscle cellsThe Japanese Journal of Pharmacology, 1990
- Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino‐atrial node cells.The Journal of Physiology, 1988
- Calcium Antagonists in HypertensionJournal of Cardiovascular Pharmacology, 1987
- Clinical outcome after treatment of rest angina with calcium blockers: Comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamilAmerican Heart Journal, 1983
- Species variation in arterial-myocardial sensitivity to verapamilCardiovascular Research, 1981
- Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.Circulation, 1980